Chemical Space Docking™ Beta Test Phase Ends August 31 – Deadline passed

Events

Chemical Space Docking™ Beta Test Phase Ends August 31 – Deadline passed

July 19, 2024 01:27 CEST

Deadline to Apply: August 31, 2024

Are you looking for the next big thing in drug discovery? Look no further than Chemical Space Docking™ — BioSolveIT’s innovative approach to exploring more than billions of chemical compounds.

Chemical Space Docking™ is a novel structure-based exploration method that mines the best drug candidates with exceptional efficiency and sophistication. Unlike conventional virtual screening that relies on brute-force docking of compounds, this technology prioritizes the selection of the most promising candidates that effectively extend into the target binding site.

The interactive workflow of Chemical Space Docking™ enables you to guide the process at every stage, ensuring your project’s success. The results retrieved are synthetically accessible and commercially available, ready for further development.

As a beta tester, you will be among the first to experience the power of Chemical Space Docking™ before it becomes widely available. This is your opportunity to preview the technology and provide feedback that will shape the final product.

Some key advantages of Chemical Space Docking™ include:

  • Save Time: Docking billions of compounds can take months to years, but Chemical Space Docking™ can achieve the same in just days.
  • Interactive Workflow: Apply your expertise by guiding the process with pharmacophore constraints and visually inspecting the results.
  • Access to Diverse Chemical Spaces: Collaborate with our partners to explore unique compound collections.
  • Sophisticated User Interface: The easy-to-use SeeSAR platform makes Chemical Space Docking™ accessible to medicinal chemists and drug discovery beginners alike.
  • No Need for Extensive Computational Resources: Chemical Space Docking™ runs on standard hardware, making it available to smaller companies and research groups.
  • Retrieval of Molecular Novelty: The technology has been shown to mine novel and potent chemotypes from Chemical Spaces.

To apply for the beta testing program, please submit your application by August 31, 2024. As a successful applicant, you will receive access to SeeSAR and its Chemical Space Docking™ mode, allowing you to explore billions of compounds and discover the next generation of drug candidates.

Don’t miss this opportunity to be at the forefront of Chemical Space exploration. Apply now and be part of the revolutionary journey!

Thank you to everyone who expressed interest in our Chemical Space Docking™ beta testing program. The application deadline has now passed as of August 31, 2024. We appreciate all the applications we received and are excited to begin this journey with our selected beta testers. Stay tuned for further updates!